Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis

Charles M. Nolan, Diana L. Williams, M. Donald Cave, Kathleen D. Eisenach, Hiyam El-Hajj, Thomas Hooton, Robert L. Thompson, Stefan V. Coldberc

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Acquired rifampin resistance without preexisting isoniazid resistance is highly unusual in patients with tuberculosis. The purpose of this report is to describe and characterize that unusual pattern of acquired drug resistance in three patients with human immunodeficiency virus (HIV) infection. The patients originally had Mycobacterium tuberculosis strains that were susceptible to isoniazid and rifampin. During treatment in two patients and after completion of therapy in the remaining one, each patient developed active, rifampin-resistant, isoniazid-susceptible tuberculosis. One patient subsequently developed isoniazid resistance also. Studies on patients' M. tuberculosis isolates using IS6110 restriction fragment length polymorphism typing and rpoB gene sequencing indicated that rifampin resistance in each patient arose during therapy by an rpoB gene mutation in the original M. tuberculosis isolate. Detection of this unusual drug-resistance phenotype in three patients with HIV infection suggests that acquired rifampin resistance is somehow associated with co-infection due to HIV and tuberculosis.

Original languageEnglish
Pages (from-to)1067-1071
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume152
Issue number3
StatePublished - Sep 1 1995
Externally publishedYes

Fingerprint

Rifampin
Tuberculosis
HIV
Isoniazid
Mycobacterium tuberculosis
Virus Diseases
Drug Resistance
Coinfection
Restriction Fragment Length Polymorphisms
Genetic Therapy
Phenotype
Mutation
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Nolan, C. M., Williams, D. L., Cave, M. D., Eisenach, K. D., El-Hajj, H., Hooton, T., ... Coldberc, S. V. (1995). Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. American Journal of Respiratory and Critical Care Medicine, 152(3), 1067-1071.

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. / Nolan, Charles M.; Williams, Diana L.; Cave, M. Donald; Eisenach, Kathleen D.; El-Hajj, Hiyam; Hooton, Thomas; Thompson, Robert L.; Coldberc, Stefan V.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 152, No. 3, 01.09.1995, p. 1067-1071.

Research output: Contribution to journalArticle

Nolan, CM, Williams, DL, Cave, MD, Eisenach, KD, El-Hajj, H, Hooton, T, Thompson, RL & Coldberc, SV 1995, 'Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis', American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 3, pp. 1067-1071.
Nolan, Charles M. ; Williams, Diana L. ; Cave, M. Donald ; Eisenach, Kathleen D. ; El-Hajj, Hiyam ; Hooton, Thomas ; Thompson, Robert L. ; Coldberc, Stefan V. / Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. In: American Journal of Respiratory and Critical Care Medicine. 1995 ; Vol. 152, No. 3. pp. 1067-1071.
@article{5fdf2c9864454ab58aa7f5ac5ec9b111,
title = "Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis",
abstract = "Acquired rifampin resistance without preexisting isoniazid resistance is highly unusual in patients with tuberculosis. The purpose of this report is to describe and characterize that unusual pattern of acquired drug resistance in three patients with human immunodeficiency virus (HIV) infection. The patients originally had Mycobacterium tuberculosis strains that were susceptible to isoniazid and rifampin. During treatment in two patients and after completion of therapy in the remaining one, each patient developed active, rifampin-resistant, isoniazid-susceptible tuberculosis. One patient subsequently developed isoniazid resistance also. Studies on patients' M. tuberculosis isolates using IS6110 restriction fragment length polymorphism typing and rpoB gene sequencing indicated that rifampin resistance in each patient arose during therapy by an rpoB gene mutation in the original M. tuberculosis isolate. Detection of this unusual drug-resistance phenotype in three patients with HIV infection suggests that acquired rifampin resistance is somehow associated with co-infection due to HIV and tuberculosis.",
author = "Nolan, {Charles M.} and Williams, {Diana L.} and Cave, {M. Donald} and Eisenach, {Kathleen D.} and Hiyam El-Hajj and Thomas Hooton and Thompson, {Robert L.} and Coldberc, {Stefan V.}",
year = "1995",
month = "9",
day = "1",
language = "English",
volume = "152",
pages = "1067--1071",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis

AU - Nolan, Charles M.

AU - Williams, Diana L.

AU - Cave, M. Donald

AU - Eisenach, Kathleen D.

AU - El-Hajj, Hiyam

AU - Hooton, Thomas

AU - Thompson, Robert L.

AU - Coldberc, Stefan V.

PY - 1995/9/1

Y1 - 1995/9/1

N2 - Acquired rifampin resistance without preexisting isoniazid resistance is highly unusual in patients with tuberculosis. The purpose of this report is to describe and characterize that unusual pattern of acquired drug resistance in three patients with human immunodeficiency virus (HIV) infection. The patients originally had Mycobacterium tuberculosis strains that were susceptible to isoniazid and rifampin. During treatment in two patients and after completion of therapy in the remaining one, each patient developed active, rifampin-resistant, isoniazid-susceptible tuberculosis. One patient subsequently developed isoniazid resistance also. Studies on patients' M. tuberculosis isolates using IS6110 restriction fragment length polymorphism typing and rpoB gene sequencing indicated that rifampin resistance in each patient arose during therapy by an rpoB gene mutation in the original M. tuberculosis isolate. Detection of this unusual drug-resistance phenotype in three patients with HIV infection suggests that acquired rifampin resistance is somehow associated with co-infection due to HIV and tuberculosis.

AB - Acquired rifampin resistance without preexisting isoniazid resistance is highly unusual in patients with tuberculosis. The purpose of this report is to describe and characterize that unusual pattern of acquired drug resistance in three patients with human immunodeficiency virus (HIV) infection. The patients originally had Mycobacterium tuberculosis strains that were susceptible to isoniazid and rifampin. During treatment in two patients and after completion of therapy in the remaining one, each patient developed active, rifampin-resistant, isoniazid-susceptible tuberculosis. One patient subsequently developed isoniazid resistance also. Studies on patients' M. tuberculosis isolates using IS6110 restriction fragment length polymorphism typing and rpoB gene sequencing indicated that rifampin resistance in each patient arose during therapy by an rpoB gene mutation in the original M. tuberculosis isolate. Detection of this unusual drug-resistance phenotype in three patients with HIV infection suggests that acquired rifampin resistance is somehow associated with co-infection due to HIV and tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=0029082991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029082991&partnerID=8YFLogxK

M3 - Article

C2 - 7663785

AN - SCOPUS:0029082991

VL - 152

SP - 1067

EP - 1071

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -